Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update-Reference-Cited by-同舟云学术

Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update

Published:2024-08-29 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Cornet Nicole¹^ORCID,Aboubakr Aiya²^ORCID,Ahmed Waseem³^ORCID,Battat Robert⁴^ORCID

Affiliation:

1. Department of Medicine, NewYork Presbyterian-Weill Cornell Medicine , New York, NY , USA

2. Division of Gastroenterology, NewYork Presbyterian-Weill Cornell Medicine , New York, NY , USA

3. Department of Gastroenterology, University of Colorado Crohn’s and Colitis Center , Aurora, CO , USA

4. Department of Gastroenterology and Hepatology, Center Hospitalier de l’ Université de Montreal , Montreal, QC , Canada

Abstract

Lay Summary This article discusses the rationale for and the current data on the efficacy and safety of combined advanced targeted therapy (CATT) for the treatment of moderate-to-severe inflammatory bowel disease.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izae189/58963787/izae189.pdf

Reference44 articles.

1. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort;Thia;Gastroenterology.,2010

2. Risk factors for surgery and postoperative recurrence in Crohn’s disease;Bernell;Ann Surg.,2000

3. Contemporary risk of surgery in patients with ulcerative colitis and Crohn’s disease: a meta-analysis of population-based cohorts;Tsai;Clin Gastroenterol Hepatol.,2021

4. The pattern and outcome of acute severe colitis;Dinesen;J Crohns Colitis.,2010

5. Review article: the practical management of acute severe ulcerative colitis;Seah;Aliment Pharmacol Ther.,2016